Conclusions
Dual-energy X-ray absorptiometry has become the standard for the evaluation of osteoporosis. It is useful both for identifying those people who are going to be at risk of fracture in the future, and for monitoring therapy when the measurements are made at the lumbar spine. A useful alternative for the measurement of osteoporosis risk would be ultrasound measurements of the heel. An alternative approach to monitoring therapy would be by measuring the biochemical markers of bone turnover.
Similar content being viewed by others
References
A Consensus development conference: diagnosis, prophylaxis and treatmentof osteoporosis. Am J Med 1991;90:107–10.
Report of a WHO study group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843. WHO: Geneva 1994.
Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72–5.
Porter RW, Miller CG, Granger D, Palmer SB. Prediction of hip fracture in elderly women: a prospective study. BMJ 1990;301:638–41.
Liberman VA, Weiss SR, Brull J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437–43.
Eastell R. Biochemical markers. Spine, State of the Art Review 1994;8:155–70.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eastel, R. Assessment of bone density and bone loss. Osteoporosis Int 6 (Suppl 2), 3–5 (1996). https://doi.org/10.1007/BF01625232
Issue Date:
DOI: https://doi.org/10.1007/BF01625232